Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
May 29, 2019
Vor Biopharma Announces Publication of Proof-of-Concept Study of its Lead Program in the Scientific Journal PNAS
May 29, 2019
Arvinas Receives Fast Track Designation For Its Targeted Protein Degrader ARV-110 As A Treatment For Men With Metastatic Castration-Resistant Prostate Cancer
May 24, 2019
IDEAYA Announces Pricing of Initial Public Offering
May 17, 2019
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
May 17, 2019
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
May 17, 2019
Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
May 17, 2019
IDEAYA Receives Authorization to Proceed with Phase 1/2 Tissue-Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ/11 Mutations and PKC Fusions
May 17, 2019
Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility
May 17, 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
April 15, 2019
Cidara Selects First Clinical Development Candidate From Its Cloudbreak Influenza (Antiviral) Program
« Previous Page
1
…
7
8
9
10
11
12
Next Page »